LSKL - Inhibitor of Thrombospondin (TSP-1). CAS# 283609-79-0 Size:2mg solid InChi: InChI=1S/C57H64N12O9S/c1-79-24-23-42(51(59)72)64-55(76)46(26-33-29-60-39-16-8-5-13-36(33)39)69-57(78)48(28-35-31-62-41-18-10-7-15-38(35)41)68-54(75)45(25-32-11-3-2-4-12-32)66-56(77)47(27-34-30-61-40-17-9-6-14-37(34)40)67-53(74)44(19-21-49(58)70)65-52(73)43-20-22-50(71)63-43/h2-18

Name: LSKL - Inhibitor of Thrombospondin (TSP-1). CAS# 283609-79-0 Size:2mg solid InChi: InChI=1S/C57H64N12O9S/c1-79-24-23-42(51(59)72)64-55(76)46(26-33-29-60-39-16-8-5-13-36(33)39)69-57(78)48(28-35-31-62-41-18-10-7-15-38(35)41)68-54(75)45(25-32-11-3-2-4-12-32)66-56(77)47(27-34-30-61-40-17-9-6-14-37(34)40)67-53(74)44(19-21-49(58)70)65-52(73)43-20-22-50(71)63-43/h2-18
Brand: amysnellpt.com
SKU: 68787326358
Price: 130.00 USD
Availability: InStock
Rating: 4.7371 (11 reviews)

SKU: 68787326358

4.7

USD130.00 USD173.00

Pay in 4 interest-free payments of $32.50 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

InChi: InChI=1S/C57H64N12O9S/c1-79-24-23-42(51(59)72)64-55(76)46(26-33-29-60-39-16-8-5-13-36(33)39)69-57(78)48(28-35-31-62-41-18-10-7-15-38(35)41)68-54(75)45(25-32-11-3-2-4-12-32)66-56(77)47(27-34-30-61-40-17-9-6-14-37(34)40)67-53(74)44(19-21-49(58)70)65-52(73)43-20-22-50(71)63-43/h2-18

4-tetrahydroisoquinoline alkaloids

Sulfonamide derivative

156(1):29-36

Chemical Name: 2-{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid

LSKL - Inhibitor of Thrombospondin (TSP-1). CAS# 283609-79-0 Size:2mg solid InChi: InChI=1S/C57H64N12O9S/c1-79-24-23-42(51(59)72)64-55(76)46(26-33-29-60-39-16-8-5-13-36(33)39)69-57(78)48(28-35-31-62-41-18-10-7-15-38(35)41)68-54(75)45(25-32-11-3-2-4-12-32)66-56(77)47(27-34-30-61-40-17-9-6-14-37(34)40)67-53(74)44(19-21-49(58)70)65-52(73)43-20-22-50(71)63-43/h2-18LSKL, Inhibitor of Thrombospondin (TSP 1) is a latency associated protein (LAP) TGF derived tetrapeptide and a competitive TGF 1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP 1) inhibits the binding of TSP 1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP 1) suppresses subarachnoid fibrosis via inhibition of TSP 1 mediated TGF 1 activity, prevents the development of chronic

Exchange/Return Notes